Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial - The Lancet Infectious Diseases
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis - Journal of the American Academy of Dermatology
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician | JCO Precision Oncology
Dose ranging patterns in dose finding studies. Range of doses (ratio of... | Download Scientific Diagram
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors | Scientific Reports
Statistical considerations in exploratory studies
PHASE I/II CLINICAL TRIAL DESIGN AND DOSE FINDING (PART I)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study | PLOS ONE
LEA29Y phase II dose-finding study design. | Download Scientific Diagram
A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician | JCO Precision Oncology
Dose Finding in Oncology: What is Impeding Coming of Age? | SpringerLink
Figure 1 from Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma | Semantic Scholar
Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis - Journal of the American Academy of Dermatology
Adaptive Dose-Finding Designs: Improving Development Strategies - YouTube
Dose Finding Versus Speed in Seamless Immunoâ•'Oncology Drug Development
![PDF] Dose finding study of Sahaj Vati (comprised of Shilajeet, Haridra, Guggul and Chitrak ) in validated animal model of obesity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/69a9b67ea78db487b0cc05b6b5a5edfd60c75363/3-Table2-1.png "PDF] Dose finding study of Sahaj Vati (comprised of Shilajeet, Haridra, Guggul and Chitrak ) in validated animal model of obesity | Semantic Scholar")
PDF] Dose finding study of Sahaj Vati (comprised of Shilajeet, Haridra, Guggul and Chitrak ) in validated animal model of obesity | Semantic Scholar
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
Adaptive Dose-finding Design
Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis - ScienceDirect
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
How to design a dose-finding study on combined agents: Choice of design and development of R functions | PLOS ONE
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
